However, tumor tissue exhibited higher levels of immune checkpoint-related ligand-receptors, such as LGALS9-HAVCR2, LAGALS9-CD44, ICOSL-ICOS, ICOSL-CTLA4, and ICOSL-CD28. Here, LGALS9 is linked to neoplasm.